Generative AI for Drug Discovery Hit Identification and Optimization

Watch a 23-minute symposium talk exploring the development and application of generative AI techniques in drug discovery, specifically focusing on hit identification and optimization. Learn from Henry van den Bedem, senior vice president of machine learning research and cheminformatics at Atomwise Inc. and Associate Adjunct Professor at UCSF, as he shares insights into how artificial intelligence is revolutionizing the drug development process. Gain valuable knowledge about the intersection of machine learning and pharmaceutical research from this presentation delivered at the Broad Institute's Machine Learning in Drug Discovery Symposium.